gastrointestinal disease | GenomeWeb

gastrointestinal disease

The firm received the CE IVD mark for Amplidiag Easy, an automated system that enables nucleic acid extraction and PCR setup directly from stool samples.

The agreement with PerkinElmer's Wallac Oy subsidiary will bring Mobidiag's real-time PCR-based gastrointestinal tests to a new market.

The deal will help the Finnish diagnostics company expand its offerings of PCR-based gastrointestinal diagnostic tests.

CeMeT, short for Center for Metagenomics, was founded in 2014 as a spinout from genetic diagnostics firm CeGaT in Tübingen.

A study of gut microbes in infants with or without necrotizing enterocolitis points to a uropathogenic Escherichia coli association in infected preterm infants

Under a four-year agreement, Unilabs will offer Mobidiag's Amplidiag products in Sweden and Norway.

Using Quanterix's Simoa technology, the group developed assays to detect C. diff toxins with a high degree of sensitivity and specificity.

Two new projects announced last week will showcase organ-on-chip technology developed at the Wyss Institute.

The scientists will use gut-on-a-chip technology to develop probiotics that can sense and respond to pathogenic microbes that have made their way into a person's GI  system.

The company has also received approvals for various molecular diagnostics in the US and Canada in recent months.

Pages

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.